A drug targeting the USAG-1 protein entered human trials in Japan in 2024. Researchers aim to make third tooth regrowth available by 2030.
Author: Julie Hambleton
Browse all articles by this author
The gelatin natural ozempic trend is going viral, but dietitians say the comparison to semaglutide is a massive exaggeration.
New 2026 research reveals surprising coffee side effects on gut health, memory, and mood — plus what the latest studies say about heart disease
Stanford Medicine's June 2026 study in Science found that blocking the aging protein 15-PGDH restored lost cartilage in mice and regrew
Hot water weight loss claims are everywhere, but the research shows temperature doesn't drive results.
Dryer sheets health risks are real: oncologists explain the VOCs, hidden fragrance chemicals, and safer alternatives to protect your health.
Ambien side effects go far beyond drowsiness. From sleep driving and memory blackouts to dementia risk
The US 2025-2030 new food pyramid diet doubles protein targets, endorses beef tallow and full-fat dairy
The Trump administration is pushing whole milk back into schools and the 2025-2030 dietary guidelines.
Aleve long-term side effects include kidney damage, heart risk, and GI bleeding — often without warning.
The EU banned 15 cancer-linked cosmetics chemicals banned in Europe as of May 2026. Here's what they are and why the US still allows them.
A 2026 study found compounds from a Brazilian tree kill COVID in the lab, matching the potency of remdesivir and molnupiravir across multiple